Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02991846
What this trial is testing

A Prospective Observational Study for Evaluating CGVHD

Who this might be right for
Chronic Graft-Versus-Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 248
Not applicableStudy completedNCT00579397
What this trial is testing

Markers of Inflammation in Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host Disease
Ann & Robert H Lurie Children's Hospital of Chicago 30
Early research (Phase 1)Ended earlyNCT04006652
What this trial is testing

ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

Who this might be right for
Acute Graft Versus Host DiseaseHaploidentical Hematopoietic Stem Cell Transplant
Washington University School of Medicine 4
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Ended earlyNCT03963024
What this trial is testing

Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

Who this might be right for
Irradiated Bone MarrowTransplant-Related Hematologic MalignancyLeukemia, Acute+2 more
IRCCS San Raffaele 9
Not applicableStudy completedNCT03093805
What this trial is testing

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin

Who this might be right for
Graft Vs Host Disease
Children's Hospital Medical Center, Cincinnati 10
Not applicableStudy completedNCT00333190
What this trial is testing

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic MalignancyAMLALL+4 more
Dana-Farber Cancer Institute 30
Not applicableStudy completedNCT03009708
What this trial is testing

Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen

Who this might be right for
Allograft
Institut de Cancérologie de la Loire 15
Testing effectiveness (Phase 2)Study completedNCT00353860
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

Who this might be right for
ImmunosuppressionLeukemia
National Heart, Lung, and Blood Institute (NHLBI) 70
Not applicableStudy completedNCT03575767
What this trial is testing

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host Disease+1 more
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT06626737
What this trial is testing

Dapagliflozin in Allo-HCT for aGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University 72
Testing effectiveness (Phase 2)UnknownNCT05914714
What this trial is testing

Ruxolitinib as GVHD Prophylaxis in AA Patients

Who this might be right for
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
Institute of Hematology & Blood Diseases Hospital, China 46
Large-scale testing (Phase 3)Study completedNCT00004255
What this trial is testing

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Chimeric Therapies
Early research (Phase 1)Ended earlyNCT00943293
What this trial is testing

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Who this might be right for
PreleukemiaMyeloproliferative DisordersLymphoma+2 more
University of Chicago 1
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT05090384
What this trial is testing

Pediatric GVHD Low Risk Steroid Taper Trial

Who this might be right for
Acute Graft vs Host DiseaseAllogeneic Bone Marrow TransplantationAdverse Effects
John Levine 50
Large-scale testing (Phase 3)Study completedNCT02461121
What this trial is testing

HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156
Large-scale testing (Phase 3)Study completedNCT04167514
What this trial is testing

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Who this might be right for
Graft Versus Host Disease (GVHD)
CSL Behring 136
Testing effectiveness (Phase 2)Study completedNCT00823316
What this trial is testing

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Leukemia
Medipost Co Ltd. 10
Large-scale testing (Phase 3)Ended earlyNCT01749111
What this trial is testing

Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disease+3 more
Hospital Israelita Albert Einstein 3
Next Page